Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalon GloboCare (ALBT) Gains from Sales and Divestitures (2017 - 2025)

Avalon GloboCare (ALBT) has 8 years of Gains from Sales and Divestitures data on record, last reported at $80000.0 in Q3 2025.

  • For Q3 2025, Gains from Sales and Divestitures changed N/A year-over-year to $80000.0; the TTM value through Sep 2025 reached $80000.0, changed N/A, while the annual FY2022 figure was $86583.0, 0.97% up from the prior year.
  • Gains from Sales and Divestitures reached $80000.0 in Q3 2025 per ALBT's latest filing, roughly flat from $80000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $651668.0 in Q3 2021 and bottomed at $19137.0 in Q1 2023.
  • Average Gains from Sales and Divestitures over 4 years is $260482.3, with a median of $212501.0 recorded in 2022.
  • Peak YoY movement for Gains from Sales and Divestitures: plummeted 95.73% in 2021, then rose 0.97% in 2022.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $85750.0 in 2021, then grew by 0.97% to $86583.0 in 2022, then surged by 107.89% to $179998.0 in 2023, then plummeted by 55.56% to $80000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $80000.0 in Q3 2025, $80000.0 in Q2 2025, and $179998.0 in Q3 2023.